Health & Fitness:Medicine
Alemtuzumab’s impact on functional and structural integrity of the visual system in MS
2021-11-17
Prof Michael Barnett, Director Sydney Neuroimaging Analysis Centre and Professor of Neurology, University of Sydney, joins JNNP's Podcast Editor, Colin Mahoney, to discuss how the use of Alemtuzumab may have longer-term impacts on improving one of the most commonly involved neurological pathways, the visual system, in multiple sclerosis (MS).
Prof Barnett discusses his team's results after following up patients with highly active MS for 24 months, using multifocal visual evoked potentials and advanced neuroimaging. He also talks about what this means for future remyelination strategies.
view more
Related paper: https://jnnp.bmj.com/content/92/12/1319
More Episodes
Can cocoa help with fatigue in MS
2019-05-28
97
2019-05-28
97
Neurorehabilitation in chronic stroke
2019-05-08
109
2019-05-08
109
The real patient value
2019-04-18
70
2019-04-18
70
Medical conferences - what do we get out of them?
2019-04-04
73
2019-04-04
73
Oral immunotherapies in MS a comparison of efficacy.
2019-03-25
80
2019-03-25
80
Therapeutic trial design in frontotemporal dementias
2019-03-20
80
2019-03-20
80
Do genes affect age of onset in ALS?
2019-03-11
84
2019-03-11
84
PMA and PLS: are they really restricted phenotypes?
2019-02-04
85
2019-02-04
85
Functional impairment and improvement
2018-12-10
81
2018-12-10
81
Nusinersen for SMA
2018-08-29
75
2018-08-29
75
The use of cannabis in epilepsy, and surgery for tremor
2018-07-02
89
2018-07-02
89
Epilepsy an evidence update
2018-05-31
104
2018-05-31
104
The Use of Frankincense Extract In MS
2018-04-04
73
2018-04-04
73
Get this podcast on your
phone, FREE
